Key terms
About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AZN news
Today
2:21am ET
Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Intuitive Surgical (ISRG) and IN8bio (INAB)
Yesterday
2:01am ET
QQQ ETF Update, 3/18/2024
Mar 15
12:03pm ET
JPMorgan biotech/pharma analysts hold an analyst/industry conference call
Mar 13
11:00am ET
European Stocks: Unnoticed Records, Overlooked Opportunities
Mar 13
7:10am ET
AstraZeneca initiates Breztri Aerosphere trial, doses first ATHLOS patients
Mar 13
5:21am ET
AstraZeneca downgraded to Neutral from Outperform at Oddo BHF
Mar 08
6:45am ET
Major Stocks Scale New Highs as Indices Set New Records
Mar 06
12:07am ET
QQQ ETF Update, 3/6/2024
Mar 04
8:38am ET
AstraZeneca price target lowered to 11,100 GBp from 11,800 GBp at Guggenheim
Mar 04
5:23am ET
EMA validates two MAAs for Daiichi Sankyo, AstraZeneca datopotamab deruxtecan
Feb 29
12:53am ET
QQQ ETF Update, 2/29/2024
Feb 27
1:04am ET
QQQ ETF Update, 2/27/2024
Feb 26
4:15pm ET
FibroGen, AstraZeneca terminate U.S./RoW roxadustat collaboration agreement
Feb 26
6:48am ET
AstraZeneca says Voydeya recommended for approval in the EU by CHMP
Feb 23
1:28pm ET
AstraZeneca says benralizumab met primary endpoint of MANDARA trial
Feb 23
9:40am ET
Unusually active option classes on open February 23rd
Feb 23
8:08am ET
Silence Therapeutics to receive $10M from AstraZeneca following trial initiation
Feb 23
1:11am ET
QQQ ETF Update, 2/23/2024
Feb 22
8:48am ET
Gracell announces completion of acquisition
Feb 22
12:17am ET
AstraZeneca’s Growth Potential Bolstered by Strong Pipeline and Strategic Acquisitions: A Buy Rating Justified
Feb 21
1:43am ET
QQQ ETF Update, 2/21/2024
Feb 20
1:59pm ET
AstraZeneca price target lowered to $75.50 from $80 at Berenberg
Feb 20
1:40pm ET
AstraZeneca price target lowered to 12,000 GBp from 12,500 GBp at Berenberg
Feb 20
9:40am ET
Unusually active option classes on open February 20th
Feb 20
6:34am ET
AstraZeneca says datopotamab deruxtecan BLA accepted in U.S.
Feb 20
6:05am ET
AstraZeneca: Strong Buy Recommendation on Robust Growth and Favorable Valuation
Feb 19
7:43am ET
AstraZeneca announces results from LAURA Phase III trial
Feb 18
9:19am ET
Ex-Dividend Date Nearing for These 10 Stocks – Week of February 19, 2024
Feb 16
6:22pm ET
AstraZeneca’s Tagrisso approved by FDA in NSCLC
Feb 15
1:16am ET
AstraZeneca: A Buy Rating with Promising Growth and Strategic R&D Outlook Despite Near-Term Challenges
Feb 14
8:57am ET
AIM ImmunoTech announces first subject dosed in Netherlands for Ampligen study
No recent news articles are available for AZN
No recent press releases are available for AZN
AZN Financials
Key terms
Ad Feedback
AZN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AZN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range